We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Consulting AgreementConsulting Agreement • March 14th, 2023 • Sigilon Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 14th, 2023 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”), is made as of February 14, 2023 (the “Effective Date”) by and between Sigilon Therapeutics, Inc. (the “Company”), with offices at 100 Binney Street, Suite 600, Cambridge, MA 02142, and Rare Disease and Oncology Consulting, LLC/ May Orfali, MD, MBA (the “Consultant”).
CONSULTING AGREEMENT [May Orfali, MD, MBA]Consulting Agreement • March 14th, 2022 • Sigilon Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 14th, 2022 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”), is made as of October 13, 2021 (the “Effective Date”) by and between Sigilon Therapeutics, Inc. (the “Company”), with offices at 100 Binney Street, Suite 600, Cambridge, MA 02142, and Rare Disease and Oncology Consulting, LLC, (the “Consultant”).